Showing results (2871-2880 of 5,702) with videos related to

Sort By:
Pageof 571
The Oncologist|November 17, 2025
Real-life follow-up after discontinuation of anti-PD1 therapy for complete-response cutaneous squamous cell carcinoma in patients over 75 years of ageJulie Lardenois, Eve Desmedt, Sophie Maiezza, et al.
The Oncologist|October 13, 2025
Real-world effectiveness of mitoxantrone hydrochloride liposome containing regimens in acute myeloid leukemiaTie-Jun Gong, Wei-Ming Li, Li Liu, et al.
The Oncologist|October 6, 2025
Antibody drugs conjugates in non-small cell lung cancer: current status and challengesArjun Syal, May-Lucie Meyer, Kenneth Angelino, et al.
The Oncologist|October 6, 2025
Guiding first-line treatment decisions in advanced urothelial carcinoma: a global surveyEnrique Grande, Joaquim Bellmunt, Syed A Hussain, et al.
The Oncologist|September 27, 2025
Intravenous haloperidol or chlorpromazine-which is more effective to improve agitation and communication in agitated delirium at the end of life?Megumi Uchida, Tatsuya Morita, Tatsuo Akechi, et al.
The Oncologist|September 27, 2025
Efficacy and safety of Rh-endostatin in the treatment of radiation pneumonitis in non-small cell lung cancerGuangpeng Chen, Jianbo Zhu, Chunli Jian, et al.
The Oncologist|September 27, 2025
Prognostic value of miR-21 in colorectal cancer, pancreatic ductal adenocarcinoma, and esophageal squamous cell carcinoma: updated systematic review and meta-analysisJing Huang, Qiang He, Jufang Wang, et al.
The Oncologist|September 25, 2025
A cohort study of circulating biomarkers to predict the efficacy and prognosis of immune combination therapy in non-small-cell lung cancerYanxia Liu, Xiaomi Li, Minghang Zhang, et al.
The Oncologist|September 26, 2025
Clinical perspective on management of key adverse events with sacituzumab govitecanSara M Tolaney, Guru P Sonpavde, Paolo Tarantino, et al.
The Oncologist|September 26, 2025
Validation of the FACIT-Fatigue scale in patients with locally advanced or metastatic breast cancerAlessandra Fabi, Steven Hager, Laura Lourdes, et al.
Pageof 571